Immunogenicity of human and bovine insulin in type 1 diabetes mellitus patients

Diabetes Technology and Therapeutics

Volumn 10, Issue 4, 2008, Pages 305-309

  Himanshu, M ^a   Bhat, Chetan B ^a   Ramchandran, Sarita ^a   Bhat, K Geetha ^a   Kumar, Prasanna K M ^a,b  

^a M S RAMAIAH MEDICAL COLLEGE   (India)

^b M S RAMAIAH UNIVERSITY OF APPLIED SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE INSULIN; HUMAN INSULIN; INSULIN ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DIABETIC PATIENT; HUMAN; IMMUNOGENICITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MINIPUMP; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANK SUM TEST;

ADOLESCENT; ADULT; ANIMALS; CATTLE; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN ANTIBODIES; MALE; RADIOIMMUNOASSAY; RECOMBINANT PROTEINS;

EID: 50049136009     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2007.0294     Document Type: Article

References (28)

1. th ed. London: Elsevier Saunders, 2005:1104-1105.
2. Chance RE, Root MA, Galloway JA: The immunogenicity of insulin preparations. Acta Endocrinol Suppl (Copenh) 1976;205:185-198.
3. Smith LF: Amino acid sequences of insulins. Diabetes 1972;21(2 Suppl):457-460.
4. Richter B, Neises G: 'Human' insulin versus animal insulin in people with diabetes mellitus. Cochrane Database Syst Rev 2005(1):CD003816.
5. Goswami R JA, Kochupillai NP: Insulin antibody response to bovine insulin therapy: functional significance among insulin requiring young diabetics in India. Diabetes Res Clin Pract 2000;49:7-15.
6. Miglani S, Goswami R, Tandon N, Dudha A, Kochupillai N: Glycaemic control and microvascular complication among patients with youth onset diabetes in India using differing types of insulin and methods of glucose monitoring. Diabetes Res Clin Pract 2004;65:183-185.
7. Dixon K: Measurement of antibodies on insulin in serum. Clin Chem 1974;20:1275-1281.
8. Desbuquois B, Aurbach GD: Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 1971;33:732-738.
9. Kansal PC, Bandisode MS, Boshell BR: Determination of insulin antibodies. Horm Metab Res 1979;11:187-189.
10. Kruskal WH, Wallis WA: Use of ranks in one-criterion variance analysis. J Am Stat Assoc 1952;47:583-621.
11. Mann HB, Whitney DR: On a test of whether one of two random variables is stochastically larger than the other. Ann Math Stat 1947;18:50-60.
12. th ed. Hyderabad: International Book Bureau, 1979:462.
13. Fireman P, Fineberg SE, Galloway JA: Development of IgE antibodies to human (recombinant DNA), porcine, and bovine insulins in diabetic subjects. Diabetes Care 1982;5(Suppl 2):119-125.
14. Brogden RN, Heel RC: Human insulin. A review of its biological activity, pharmacokinetics and therapeutic use. Drugs 1987;34:350-371.
15. Bodtger U, Wittrup M: A rational clinical approach to suspected insulin allergy: status after five years and 22 cases. Diabet Med 2005;22:102-106.
16. Witters LA, Ohman JL, Weir GC, Raymond LW, Lowell FC: Insulin antibodies in the pathogenesis of insulin allergy and resistance. Am J Med 1977;63:703-709.
17. Lam HC, Ho LT, Tang KT, Wang LM, Kwok CF, Liu YF, Hsiao LJ, Li SH: Immunogenicity of highly purified porcine and human insulins in diabetic patients with high titers of insulin antibody. Taiwan Yi Xue Hui Za Zhi 1989;88:346-351.
18. Home PD, Mann NP, Hutchison AS, Park R, Walford S, Murphy M, Reeves WG: A fifteen-month double-blind crossover study of the efficacy and antigenicity of human and pork insulins. Diabet Med 1984;1:93-98.
19. Ho LT, Lam HC, Wu MS, Kwok CF, Jap TS, Tang KT, Wang LM, Liu YF: A twelve month double-blind randomized study of the efficacy and immunogenicity of human and porcine insulins in non-insulin-dependent diabetics. Zhonghua Yi Xue Za Zhi (Taipei) 1991;47:313-319.
20. Wonders J, Eekhoff EM, Heine R, Bruynzeel DP, Rustemeyer T: [Insulin allergy: background, diagnosis and treatment]. Ned Tijdschr Geneeskd 2005;149:2783-2788.
21. Mianowska B, Perenc M, Heinrich A, Bodalski J: [Severe hypoglycemia and insulin antibodies levels in children and adolescents with type 1 diabetes]. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw 2003;9:29-34.
22. th ed. (Paul WE, ed.). Philadelphia: Lippincott Williams and Wilkins, 2003:81-83.
23. Greenbaum CJ, Wilkin TJ, Palmer JP: Fifth International Serum Exchange Workshop for Insulin Autoantibody (IAA) Standardization. The Immunology and Diabetes Workshops and participating laboratories. Diabetologia 1992;35:798-800.
24. Hegewald MJ, Schoenfeld SL, McCulloch DK, Greenbaum CJ, Klaff LJ, Palmer JP: Increased specificity and sensitivity of insulin antibody measurements in autoimmune thyroid disease and type I diabetes. J Immunol Methods 1992;154:61-68.
25. Tandhanand-Banchuin N, Vannasaeng S, Ploybutr S, Sriussadaporn S: Comparison of anti-human insulin antibodies detection by commercial enzyme-linked immunosorbent assay kit, displacement enzyme-linked immunosorbent assay and radioimmunoassay, in Thai diabetic patients. Diabetes Res Clin Pract 1993;22:71-82.
26. Yalow RS: Radioimmunoassay. Annu Rev Biophys Bioeng 1980;9:327-345.
27. Yalow RS, Berson SA: Immunoassay of endogenous plasma insulin in man. J Clin Invest 1960;39:1157-1175.
28. Brooks-Worrell BM, Nielson D, Palmer JP: Insulin autoantibodies and insulin antibodies have similar binding characteristics. Proc Assoc Am Physicians 1999;111:92-96.